SERUM INSTITUTE RESUMES VACCINE TRIALS AGAIN! INDIA TO GET ITS VACCINE SOON? DETAILS

Home > News Shots > India

By Saradha | Sep 13, 2020 04:04 PM

The Serum Institute of India (SII) announced it will be resuming vaccine trails in India once it gets approval from Drugs Controller General of India (DCGI). The announcement came hours after clinical trials for AstraZeneca and Oxford University's coronavirus vaccine candidate, commenced on Saturday at UK. 

Serum institute resumes coronavirus vaccine trial post dcgi approval

AstraZeneca had paused vaccine trials after one of the volunteers developed an unexplained illness. Countries such as USA, UK, Brazil and South Africa suspended trials temporarily following the incident. 

Subsequently, DCGI instructed SII to suspend phase two and three trials of the vaccine till further orders are issued. SII was asked to improve safety monitoring of the subjects who were vaccinated as a part of the trial and submit its plan and reports to DCGI. 

"Once DCGI will give us the permission to restart the trials in India, we will resume the trials," Serum Institute of India said in its statement.

Adar Poonawalla the CEO and Owner, Serum Institute of India, stated that no conclusions are to be drawn till the trials are completed.

"As I'd mentioned earlier, we should not jump to conclusions until the trials are fully concluded. The recent chains of events are a clear example why we should not bias the process and should respect the process till the end. Good news, UniofOxford," he said in a tweet.

“India's top drugs regulator granted permission to SII on August 2 to conduct phase II/III clinical trial of ChAdOx1 nCoV-19 coronavirus vaccine (recombinant) at various clinical trial sites in the country to determine its safety and immunogenicity,” Times Now reported.

அரசியல், விளையாட்டு, நாட்டுநடப்பு, குற்ற சம்பவங்கள், வர்த்தகம், தொழில்நுட்பம், சினிமா, வாழ்க்கை முறை என பலதரப்பட்ட சுவாரஸ்யமான செய்திகளை தமிழில் படிக்க இங்கு கிளிக் செய்யவும்      

RELATED NEWS STORIES

ABOUT THIS PAGE

This page contains news relating to various facts and events. The views are generally about current affiars and general topics in diversified areas such as political, international, national, and regional issues, sports, health, travel, lifestyle, technology and business. People having similar interets on the above topics will find this page useful. Serum institute resumes coronavirus vaccine trial post dcgi approval | India News.